Olivier Loeillot, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 5,426 shares at $180.00 ($977K) on 2026-09-21, disclosed to the SEC on 2026-09-22.
Scheduled sale ($977k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGEN | SELL | 2026-09-08 | $504K | — | Filing → |
| RGEN | SELL | 2026-08-21 | $977K | — | Filing → |
| RGEN | SELL | 2026-04-22 | $536K | — | Filing → |